Product Champions + Disciplined Investors

Most investors wait for proof. We read the product.

That single difference is the reason we exist, the reason our founders call us their most valuable partner, and the reason we believe a new category of venture is replacing the old one.

The Power Law isn’t wrong. It’s optimized for a speed of market that no longer exists.

Venture capital was built on the Power Law: accept that most companies fail, and hope the one giant in the portfolio returns the fund. It worked when the world moved slowly enough to wait for confirmation.

AI ended that patience. By the time a company hits the traction metrics traditional investors expect, the signal is already noise. Anyone still running that playbook is structurally late. And at AI speed, late is the same as wrong.

There’s a class of signals that show up 12–18 months before revenue: how users move through the product, which behaviors predict retention, early organic sharing before a growth team exists, and adoption patterns that show up in a community before it hits the dashboard.

These are product signals. And the shift amplifying them is hard to ignore: Fortune 1000 companies with a Chief Product Officer (CPO) have grown 10x in three years and outperform peers by ~35%. Product leaders now control the budgets. The signal was always in the product. Now so is the money.

What Product Investors do differently:
The Product Alpha Effect.™

Reading product signals well requires being close to the people who live inside products every day, infrastructure fast enough to process what you’re seeing, and the conviction to act before consensus forms.

We call this the Product Alpha Effect™. The result is a fundamentally different return profile. The industry standard for venture outlier rates is 1-in-20. Ours is 1-in-5. Four times the industry average, across multiple funds, through a full market cycle. That is not luck. That is what happens when you systematically measure the right things at the right time.

 

Where we partner with founders

Most firms develop a thesis, then hunt for companies that fit it. It’s a form of lag: the best companies get funded faster than a thesis gets formed. We invest at the Thesis Frontier. We read product signals in real time through our 600,000-strong product community, see patterns before they have a name, partner with the founder, and form the thesis around the company, not before it.

We focus on the Discovery stage, after initial product validation, before full growth velocity. The most important questions are still open: Does the product create real, lasting value? Who is the true buyer? What is the path to scale? These are product questions. We bring our 600,000 CPOs and product managers to help you answer them.

 

For founders

this means three things:

We see you before anyone else does: If you’re building something real, the people in our network will tell us.

We validate your product with real buyers: thousands of practitioners who often become customers.

And when you’re ready to scale, the relationships that already matter are already in the room.

The start of a new corporate modelCPOs drive digital and AI transformations

Budgets shift away from traditional buyers (CMO, CIO)

Traditional lead gen tactics are ineffective (call, email)

Enterprise sales now target CPOs as buyers

Groq - Mighty Capital

When we first partnered with Groq in 2020, there was no consensus thesis for inference infrastructure.

But our network of 600,000 product leaders was already telling us that inference would be the bottleneck. No revenue curve confirmed it. That was a product signal, not a market signal. We formed the conviction around the company.

The outcome: a landmark $20B deal with NVIDIA, their largest deal ever, approximately 60x since our first check.

Canela Media - Mighty Capital

Canela is the second-largest Hispanic media company in the US, reaching more than 20 million Hispanics.

We saw the product signal early: a massive, underserved audience, and helped them raise their $32M Series A, the largest ever raised by a Latina CEO. Then we connected them to the product executives who helped build their tech stack. 

From Canela Founding CEO Isabel Rafferty: “Mighty Capital is fantastic. We could not have raised our Series A without them.” 

Angle Health - Mighty Capital

When Palantir spinoff Angle Health, an AI-native InsurTech platform, needed strategic partnerships to unlock their next phase of growth, we brokered the reinsurance relationship that became a critical accelerator for the business.

Then, we co-led their $134M round.

From Angle Founding CEO Ty Wang: “I selected Mighty Capital to lead our competitive round because they helped us secure partnerships critical to scale the business.” 

Amplitude - Mighty Capital

We partnered with Amplitude, an analytics platform, before the market had decided they would win.

We nominated them for a Product Award that generated 40% more leads, brought in $5M in new revenue and cut their sales cycle from nine months to six. Our community became their buyers. Amplitude went public on NASDAQ with a $5B market cap. 

From Amplitude Founding CEO, Spenser Skates: “Mighty Capital is our best VC. Sales velocity accelerated by 30% thanks to them.”

We call it Product Investing. We believe it’s the most important shift in venture since the Power Law was named.

The best companies of the next decade will be found by reading the product earlier, more carefully, and with better intelligence than anyone else in the market. The investors who define this era will be the ones with an operating system fast enough to keep up.

 

If you are building something the market doesn’t understand yet, something where the product is ahead of the narrative, we want to partner with you.

Proof Point

  • Featured on our award-winning podcast (millions of downloads) Increased brand awareness 30%
  • Invited to our monthly round tables (dozens of CPO attendees) Increased sales velocity 30%
  • Goes public with $5Bn market cap "Our most valuable VC!" — Spenser Skates, Founding CEO